Navigation Links
Arthritis in Dogs is Now Treatable with a Newly-Released High Quality Supplement from Pear & Berry
Date:8/23/2013

WILMINGTON, Del., Aug. 23, 2013 /PRNewswire-iReach/ -- Pear & Berry, a company that specializes in producing top-quality supplements for dogs with hip and joint issues, has just announced the release of an innovative new product that provides the answer to a common question dog owners often have: how to naturally and safely treat arthritis in dogs.

(Photo: http://photos.prnewswire.com/prnh/20130823/MN68652)

As anybody who has had a dog with hip dysplasia or arthritis knows quite well, it can be devastating to watch a beloved family pet have a hard time getting around. While medication and surgery can often help, they are also very costly solutions that many dog owners simply cannot afford. In addition, the pain medications that are typically used to treat dogs with hip dysplasia and arthritis often have dangerous side effects, including chronic liver and kidney problems.

This is where a high quality, all-natural supplement like P&B Hip and Joint Support can help. P&B Hip and Joint Support was specially formulated by a biochemist who has over 28 years of experience studying and working on the complex relationships that exist between natural ingredients and their ability to help with pain relief and joint health.

Through its combination of glucosamine for dogs, chondroitin, MSM and vitamin C—all of which have at least two decades of research behind them—many dogs are able to grow and rebuild their damaged and torn cartilage, which helps them to feel much better. In addition, P&B Hip and Joint Support carries an NASC label, which means it has achieved the highest quality standards in the industry.

"Veterinarians trust glucosamine and chondroitin to prevent the erosion of joints and even reverse years of damage to the tissues that protect your dog's joints," an article on the company's website noted, adding
'/>"/>

SOURCE Pear & Berry
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Flexions Lead Osteoarthritis Drug Candidate Demonstrates Significant, Prolonged Improvement in Pain and Function in Phase 2 Trial
2. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
3. Innovations for Osteoarthritis, Sports Injuries and Orthopedic Practices
4. Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
5. United States Market for Psoriatic Arthritis Pharmacotherapy
6. TSI Healthcare adds Arthritis and Rheumatology Associates of Palm Beach to growing list of Rheumatology Clients
7. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
8. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
9. Protalex, Inc. Announces Screening Of First Patients In U.S. For New Trial Of PRTX-100 In Patients With Active Rheumatoid Arthritis
10. Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
11. Epidemiology: Rheumatoid Arthritis in China - Rapid urbanization presents favorable market potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... YORK, Dec. 21 Intra-Cellular Therapies, Inc. (ITI) announced ... from a recently completed Phase I clinical study demonstrating ... targets in the living human brain. These key ... and related disorders. Using positron emission tomography (PET) ...
... , , , BEIJING, Dec. 21 ... biopharmaceutical products in China, announced today,that Sinovac was selected by ... companies listed overseas for 2009. The honor was given to,Sinovac ... The "Competitiveness Measure" is the measuring ...
Cached Medicine Technology:Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders 2Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders 3Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders 4Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders 5Sinovac Named One of China's Top 10 Most Competitive Companies Listed Overseas in 2009 2Sinovac Named One of China's Top 10 Most Competitive Companies Listed Overseas in 2009 3
(Date:1/22/2015)... 2015 AngelWeddingDress, the premier women’s dress ... wedding dresses. View website of AngelWeddingDress.com to ... maternity wedding dresses online for a bridal party. AngelWeddingDress ... quality for them. Its maternity wedding dresses are specially ...
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... A study recently published in ... Medicine & Science in Sports & Exercise shows ... reduce gastrointestinal (GI) problems associated with physical strain ... the double-blind, placebo-controlled study took 10 grams of ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... New Director of Public Policy &,Advocacy, WASHINGTON, ... America (AAFA) has appointed Charlotte W. Collins, JD, ... AAFA, Collins was an,Associate Professor in the George ... teaching graduate courses in health law, policy,and management., ...
... kidney disease arent referred to kidney specialists in time ... a variety of reasons, according to researchers at Wake ... An analysis of 18 separate studies found that overall, ... and suffering from multiple health problems are patient characteristics ...
... Several individuals,and organizations were honored at the 89th ... today at the Hyatt Regency Princeton., NJHA,s ... F.,Lynn, former chief executive officer of AtlantiCare in ... his years of service and leadership to,AtlantiCare and ...
... Babies 2008 Official Shoes are Now On Sale, WHITE ... up with Famous Footwear(TM) and Dr. Scholl,s(R) to,introduce the 2008 ... consecutive year, Famous Footwear and Dr. Scholl,s are,raising funds for ... Scholl,s specially designed one men,s and two women,s athletic shoes ...
... is available in German . , Davos/Leipzig. ... Environmental Performance Index (EPI) can be useful for working ... environmental policy making. However, within the European Union there ... of the conclusions of a study conducted by the ...
... 29 Children,s Healthcare of Atlanta, one,of the ... investment in the future of pediatric research in ... of the Children,s,endowment toward pediatric research., "Annually, ... in pediatric research," said James E. Tally, Ph.D., ...
Cached Medicine News:Health News:Study identifies reasons patients referred late to nephrologists 2Health News:New Jersey Hospital Association Presents Awards for Commitment to Healthcare 2Health News:New Jersey Hospital Association Presents Awards for Commitment to Healthcare 3Health News:Famous Footwear, Dr. Scholl's Step Up to Support March for Babies 2008 2Health News:Lumping different countries together -- why the 2008 EPI is of limited use 2Health News:Lumping different countries together -- why the 2008 EPI is of limited use 3Health News:Children's Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision 2Health News:Children's Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: